Diseases of the spinal cord in human immunodeficiency virus infection

Seminars in Neurology

Volumn 19, Issue 2, 1999, Pages 151-155

  Di Rocco, Alessandro ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

HIV; Myelopathy; Vacuolar

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL LOSS; CELL VACUOLE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHYLATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPINAL CORD DISEASE; WHITE MATTER;

EID: 0032833053     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040832     Document Type: Review

References (59)

1. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-785
2. Petito CK, et al. Vacuolar myelopathy [[MR 4]]pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985; 312:874-879
3. Artigas J, Grosse G, Niedobitek F. Vacuolar myelopathy in AIDS. A morphological analysis. Pathol Res Pract 1990;186:228-237
4. Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlation of HIV-1 associated vacuolar myelopathy: An autopsy based case-control study. Neurology 1994;44:2159-2164
5. Tan SV, Guiloff RJ, Scaravilli F. AIDS-associated vacuolar myelopathy. A morphometric study. Brain 1995;118:1247-1261
6. Diskson DW, Belman AL, Kim TS, et al. Spinal cord pathology in pediatric acquired immunodeficiency syndrome. Neurology 1989;39:227-235
7. Sharer LR, Dowling PC, Michaels J, et al. Spinal corddisease in children with HIV-1 infection: A combined molecular biology and neuropathological study. Neuropathol Appl Neurobiol 1990;16:317-331
8. Budka H. Human immunodeficincy virus (HIV. envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 1990;79:611-619
9. Petito CK, Vecchio D, Chen YT. HIV antigen and DNA in AIDS spinal cords correlate with macrophages infiltration but not with vacuolar myelopathy. J Neuropathol Exp Neurol 19994;53:86-94
10. Rosenblum M, et al. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology 1989;39:892-896
11. Kure K, et al. Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, pediatric and fetal brains. Hum Pathol 1991;22:700-710
12. Eilbott DJ, Peress N, Burger H, et al. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophsges. Proc Natl Acad Sci USA 1989;86:3337-3341
13. Tyor WR, Glass JD, Baumrind N, et al. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 1993;43:1002-1009
14. Tan SV, Guiloff RJ, Henderson DC, et al. AIDS-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNF alpha). J Neurol Sci 1996;138:134-44
15. 12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 1989;149:2039-2041
16. Keibutz KD, Giang DW, Schiffer RB, et al. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Arch Neurol 1991;48:312-314
17. Dal Pan GJ, Allen RH, Glass JD, et al. Cobalamin (vitamin B12) dependent metabolism is not specifically altered in HIV-1 associated vacuolar myelopathy [Abstract]. Ann Neurol 1993;34:281
18. Scott JM, Molloy AM, Kennedy DG, et al. Effects of distruction of transmethylation in the central nervous system: An animal model. Acta Neurol Scand 1994; [[MR 5]](Suppl 154):27-31
19. Surtees R, Hyland K, Smith I. Central-nervous system methyl group metabolism in children with neurological complications of HIV infection. Lancet 1990;335:619-621
20. Castagna A, Le Grazie C, Accordini A, et al. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infections: Effect of parenteral treatment with SAMe. Neurology 1995;45:1678-1683
21. Tyor WR, Glas JD, Baumrind N, et al. Cytokine expression of macrophages in HIV-1 associated vacuolar myelopathy. Neurology 1993;43:1002-1009
22. McArthur JC. Neurologic manifestations of AIDS. Medicine (Baltimore) 1987;66:407-437
23. Tan SV, Guiloff RJ. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiatry 1998;65:23-28
24. Dal Pan GJ, Berger JR. Spinal cord disease in human immunodeficiency virus infection. In: Berger JR , Levy RM, eds. AIDS and the nervous system, 2nd ed. Philadelphia: Lippincott-Raven, 1997:173-187
25. Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestation of human immunodeficiency virus infecvtion in children. Pediatrics 1986;78:678-687
26. Yarchoan R, Berg G, Brouwers P, et al. Response of immunodeficiency virus-associated neurological disease to 3′-azido-3′-deoxythymidine. Lancet 1987;1:132-135
27. Di Rocco A, Tagliati M, Danisi F, et al. L-Methionine for AIDS-associated vacuolar myelopathy. Neurology 1998;51:266-268
28. Santosh CG, Bell JE, Best JJ. Spinal tract pathology in AIDS: Postmortem MRI correlation with neuropathology. Neuroradiology 1995;37:134-138
29. Barakos JA, Mark AS, Dillon WP, et al. MR imaging in acute transverse myelitis and AIDS myelopathy. J Comput Assist Tomogr 1990;14:45-50
30. Sartoretti-Schefer S, Blattler T, Wichmann W. Spinal MRI in vacuolar myelopathy, and correlation with histopathological findings. Neuroradiology 1997;39:865-869
31. Pierelli F, Garrubba C, Tilia G, et al. Multimodal evoked potentials in HIV-1-seropositive patients: Relationship between the immune impairment and the neurophysiological function. Acta Neurol Scand 1996;93:266-271
32. Jerez P, Palao A, Leiva C. HIV myelopathy as the presenting symptom of acquired immunodeficiency syndrome. Rev Neurol 1998;26:1008-1010
33. Denning DW, Anderson J, Rudge P, et al. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J 1987;294:143-144
34. Harrison LH, Vaz B, Taveira DM, et al. Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology 1997;48:13-18
35. Berger JR, Raffanti S, Svenningison A, et al. The role of HTLV in HIV-associated neurologic disease. Neurology 1991;41: 197-202
36. Mc Arthur JC, Griffin JW, Cornblath DR, et al. Steroid-responsive myeloneuropathy in a man dually infected with HIV-1 and HTLV-I. Neurology 1990;40:938-944
37. Yamasaki K, Kira J, Koyanagi Y, et al. Long-term, high dose interferon-alpha treatment in HTLV-I associated myelopathy/tropical spastic paraparesis: A combined clinical, virological and immunological sludy. J Neurol Sci 1997;147:135-144
38. Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: Recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 1998;158:957-969
39. Vinters HV, Kwok MK, Ho HW, et al. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 1989;112:245-268
40. Mahieux F, Gray F, Fenelon G, et al. Acute myeloradiculitis due to cytomegalovirus as the initial manifestation of AIDS. J Neurol Neurosurg Psychiatry 1989;52:270-274
41. Chimelli L, de Freitas MR, Bazin AR, et al. Cytomegalovirus encephalo-myelo-radiculitis in acquired immunodeficiency syndrome. Rev Neurol (Paris) 1990;146:354-360
42. Danner SA. Management of cytomegalovirus disease. AIDS 1995; 9(Suppl 2):S3-S8
43. Cline JJ, Garrett AD Combination antiviral therapy for cytomegalovirus disease in patients with AIDS. Ann Pharmacother 1997;31:1080-1082
44. Tucker T, Dix RD, Katzen C, et al. Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome. Ann Neurol 1985;18:74-79
45. Folpe A, Lapham LW, Smith HC. Herpes simplex myelitis as a cause of acute necrotizing myelitis syndrome. Neurology 1994;44:1955-1957
46. Britton CB, Mesa-Tejada R, Fenoglio CM, et al. A new complication of AIDS: Thoracic myelitis caused by herpes simplex virus. Neurology 1985;35:1071-1074
47. Lionnet F, Pulik M, Genet P, et al. Myelitis due to varicella-zoster virus in two patients with AIDS: Successful treatment with acyelovir. Clin Infect Dis 1996;22:138-140
48. Chretien F, Gray F, Lees MC, et al. Acute varicella zoster virus ventriculitis and meningo-myeloradiculitis in acquired immunodeficiency syndrome. Acta Neuropathol (Berl) 1993;86:659-665
49. Fairley CK, Wodak J, Benson E. Spinal cord toxoplasmosis in a patient with human immunodeficiency virus infection. Int J STD AIDS 1992;3:366-368
50. Poscher ME. Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: Report of four cases and review. AIDS 1994;8:1115-1117
51. Herskowitz S, Siegel SE, Schneider AT, et al. Spinal cord toxoplasmosis in AIDS. Neurology [[MR 6]] 1989:1552-1553
52. Resnick L, Comey CH, Welch WC, et al. Isolated toxoplasmosis of the thoracic spinal cord in a patient with acquired immunodeficiency syndrome. J Neurosurg 1995;82:439-496
53. Dromer F, Moulignier A, Dupont B, et al. A myeloradiculitis due to Cryptococcus curvatus in AIDS. AIDS 1995;9:395-396
54. Woods GL, Goldsmith JC. Aspergillus infection of the central nervous system in patients with acquired immunodeficiency syndrome. Arch Neurol 1990;47:181-184
55. Berger JR. Spinal cord syphilis associated with human immunodeficiency virus infection: A treatable myelopathy. Am J Med 1992;92:101-103
56. Fenelon G, Gray F, Scaravilli F, et al. Ischaemic myelopathy secondary to disseminated intravascular coagulation in AIDS. J Neurol 1991;238:51-54
57. Lallemand F, Fritsch L, Cywiner-Golenzer C, et al. Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression. J Am Acad Dermatol 1998;39:506-508
58. Klein P, Zientek G, VandenBerg SR, et al. Primary CNS lymphoma: Lymphomatous meningitis presenting as a cauda equina lesion in an AIDS patient. Can J Neurol Sci 1990;17:329-331
59. Santosh CG, Bell JE, Best JJ. Spinal tract pathology in AIDS: Postmortem MRI correlation with neuropathology. Neuroradiology 1995;37:134-138